483 Teva Parenteral Manufacturing Jan 2019

483 Teva Parenteral Manufacturing Jan 2019

Amir Alavi FDA, Adam Cooke FDA, Amanda Fyles FDA, Walden Lee FDA$119.00 - Available Now

FDA investigators audited the Teva Parenteral Manufacturing - Irvine, CA, United States facility and issued inspectional observations (via FDA 483) on 18 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Jan 2019
  • Location: Irvine, United States
  • FEI: 2027158
Add To Cart